Does LETROZOLE Cause Breast cancer recurrent? 285 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 285 reports of Breast cancer recurrent have been filed in association with LETROZOLE (Letrozole). This represents 0.9% of all adverse event reports for LETROZOLE.
285
Reports of Breast cancer recurrent with LETROZOLE
0.9%
of all LETROZOLE reports
13
Deaths
64
Hospitalizations
How Dangerous Is Breast cancer recurrent From LETROZOLE?
Of the 285 reports, 13 (4.6%) resulted in death, 64 (22.5%) required hospitalization, and 17 (6.0%) were considered life-threatening.
Is Breast cancer recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LETROZOLE. However, 285 reports have been filed with the FAERS database.
What Other Side Effects Does LETROZOLE Cause?
Neutropenia (3,683)
Fatigue (3,568)
Malignant neoplasm progression (3,445)
Nausea (2,894)
Arthralgia (2,318)
Diarrhoea (2,282)
Metastases to bone (1,735)
Dyspnoea (1,621)
Asthenia (1,589)
Vomiting (1,560)
What Other Drugs Cause Breast cancer recurrent?
TRASTUZUMAB (268)
TAMOXIFEN (260)
FULVESTRANT (219)
ANASTROZOLE (214)
CYCLOPHOSPHAMIDE (182)
RIBOCICLIB (180)
PACLITAXEL (151)
DOCETAXEL (138)
PALBOCICLIB (126)
DOXORUBICIN (114)
Which LETROZOLE Alternatives Have Lower Breast cancer recurrent Risk?
LETROZOLE vs LETROZOLE\RIBOCICLIB
LETROZOLE vs LEUCOVORIN
LETROZOLE vs LEUCOVORIN\LEUCOVORIN
LETROZOLE vs LEUPROLIDE
LETROZOLE vs LEVALBUTEROL